Sentinel lymph node biopsy using single-agent mapping tracer (blue dye) after neoadjuvant chemotherapy in a Brazilian cohort of breast cancer patients. Real world evidence

Sentinel lymph node biopsy using single-agent mapping tracer (blue dye) after neoadjuvant chemotherapy in a Brazilian cohort of breast cancer patients. Real world evidence

ABSTRACT Purpose To reduce false-negative rates (FNR) in sentinel lymph node biopsy (SLNB) of clinically positive (cN+) axilla in patients undergoing neoadjuvant chemotherapy (NAC). The removal of three or more lymph nodes with dual-tracer mapping including a radioisotope was used. However, in the...

Full description

Bibliographic Details
Main Authors: Heloisa Magda Resende, Martina Lichtenfels, Igor Camargo Soares, Angélica Araújo Cortines Laxe Renó, Ana Paula Cunha, Pedro Gustavo Falcão, Carolina Soares Pimentel Pieroni, Biazi Ricieri de Assis, Paola Cardoso, Pedro Henrique Adário Marassi, Rafael dos Santos Reis
Format: Article
Language:English
Published: Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia 2021-07-01
Series:Acta Cirúrgica Brasileira
Subjects:
Sentinel Lymph Node Biopsy
Lymph Node Excision
Neoadjuvant Therapy
Breast Neoplasms
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-86502021000600800&tlng=en

Similar Items

Similar Items